|Karolinska Development AB -- Sweden Stock|| |
SEK 5.20 0.02 0.38%
Mr. Yan Cheng was President Asia at Karolinska Development AB since July 2017. He holds B.Sc. in Business Administration. Yan is a serial entrepreneur and investor in various Swedish and Chinese life science and technology companies. Yan also has experience of financial advisory and MA between Asia and Europe, fundraising from Fortune 500 companies, and financial institutions.
Age: 31 President Since 2017
46 8 52 48 60 70 http://www.karolinskadevelopment.com
The company has return on total asset (ROA)
of (3.86) %
which means that it has lost $3.86 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of 120.96 %
meaning that it generated $120.96 on every $100 dollars invested by stockholders.
The company has accumulated 379.18 M in total debt with debt to equity ratio (D/E) of 141.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Karolinska Development AB has Current Ratio of 13.84 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Karolinska Development AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. Karolinska Development AB was founded in 2003 and is headquartered in Stockholm, Sweden. Karolinska Development operates under Pharmaceuticals And Biosciences classification in Sweden and traded on Stockholm Stock Exchange exchange.Karolinska Development AB (KDEV) is traded on Stockholm Stock Exchange in Sweden. It is located in Tomtebodav?gen 23 A and employs 13 people.